TEMPLE TREATS FIRST PATIENTS IN THE U.S. IN CLINICAL TRIAL OF NOVEL IMMUNOTHERAPY FOR PATIENTS WITH COVID-19, TEMPLE UNIVERSITY HOSPITAL

THE WISTAR INSTITUTE & ALLEVI INC. COLLABORATE ON 3D BIOPRINTING PROJECT TO ADVANCE COVID-19 RESEARCH, THE WISTAR INSTITUTE

THE STORM BREWING INSIDE: IMMUNE SYSTEMS GO WILD DURING SARS-COV-2 INFECTION, THE WISTAR INSTITUTE

THE WISTAR INSTITUTE APPOINTS CHENGYU LIANG, M.D., PH.D., AS PROFESSOR IN ITS CANCER CENTER, THE WISTAR INSTITUTION

COVID-19 AND HOW KIDS ARE GETTING HURT AT HOME, CHILDREN’S HOSPITAL OF PHILADELPHIA

CHOP ALLERGIST PRESENTS ON EOE AT INTERNATIONAL CONFERENCE, CHILDREN’S HOSPITAL OF PHILADELPHIA

CHOP’S CENTER FOR APPLIED GENOMICS RECEIVES FUNDING TO STUDY RISK OF DISEASE SPECIFICALLY IN AFRICAN AMERICANS, CHILDREN’S HOSPITAL OF PHILADELPHIA

AT-RISK TWIN PREGNANCIES BENEFIT FROM AN INTERVENTION CALLED CERCLAGE, JEFFERSON HEALTH

JEFFERSON PRESIDENT AND CEO STEPHEN KLASKO MAKES MODERN HEALTHCARE’S 2020 LIST OF INFLUENTIAL LEADERS, JEFFERSON HEALTH

JEFFERSON NAMES NEW PRESIDENT FOR ITS NEW JERSEY DIVISION, PHILADELPHIA BUSINESS JOURNAL